Mais Al-Kawaz, MD
Vascular Neurology · Lexington, KYNPI 1811378912
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $2,453 of the $3,892 with a category attached, or 63.0%. Stryker accounts for 70.3% of it on its own, with 6 other manufacturers making up the rest. Reporting peaked in 2023 at $3,077 and has fallen 95.1% since, to $150 in 2025.
Across 38 payments — averaging $102.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$3K
- Microvention, Inc.$484
- Route 92 Medical, Inc.$261
- Imperative Care, Inc$135
- Irras USA, Inc.$106
- Cook Medical LLC$89
- plus $79 from 1 others
What the payments were for
- Travel & lodging$1,43937%
- Food & beverage$2,45363%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker | 26 | $2,738 |
| Microvention, Inc. | 5 | $484 |
| Route 92 Medical, Inc. | 1 | $261 |
| Imperative Care, Inc | 1 | $135 |
| Irras USA, Inc. | 1 | $106 |
| Cook Medical LLC | 3 | $89 |
| Scientia Vascular | 1 | $79 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- EVOLVE$1,472
- TARGET$270
- 8F Base Camp Sheath System$261
- SURPASS EVOLVE$167
- ZOOM 88-T LARGE DISTAL PLATFORM$135
- TREVO$108
How this compares
Too few vascular neurology providers in Kentuckyto place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| BrilintaTicagrelor | 19 | $8,286 |
| ClopidogrelClopidogrel Bisulfate | 23 | $92 |
Paid to pharmacies, not to this prescriber.
Other vascular neurology in Lexington
- Larry GoldsteinLexington$29K
- Suhas GangadharaLexington$3K
- Homa SadeghianLexington$2K
- Jessica LeeLexington$918
- Richard MurphyLexington$108
- Kevin O'ConnorLexington$14
- Wei LiuLouisville$7K
- Tanya WarwickAshland$1K
- Tamika BurrusLouisville$267
- Roberto Chulluncuy RivasLouisville$55
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.